奧聯電子(300585.SZ)不再持有博融電子股權
格隆匯 2 月 1日丨奧聯電子(300585.SZ)公佈,公司於2020年9月15日召開了第三屆董事會第十二次會議,審議通過了《關於參股公司股權轉讓的議案》,同意公司將參股南京博融電子有限公司(“博融電子”)19%股權轉讓給南京佛城科技產業有限公司(“佛城科技”)。同日,公司與佛城科技簽署了《南京奧聯汽車電子電器股份有限公司關於南京博融電子有限公司股權轉讓協議》。
目前,上述股權轉讓事項的相關工商變更登記備案等手續已辦理完成。截至公吿披露日,公司已收到全部股權轉讓款項共計人民幣2124.20萬元。至此,此次股權轉讓事項已完成,公司不再持有博融電子的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.